Paraneoplastic cerebellar degeneration

Brain and Nerve

Volumn 62, Issue 4, 2010, Pages 357-364

  Sakai, Koichiro ^a  

^a TOKYO RINKAI HOSPITAL   (Japan)

Author keywords

Autoantibody; Cancer; Cerebellar degeneration; Onconerual antigen; Paraneoplastic syndromes

Indexed keywords

ANNA 3 ANTIBODY; AUTOANTIBODY; CARPVIII ANTIBODY; CRMP 5 ANTIBODY; CV 2 ANTIBODY; GAD ANTIBODY; HU ANTIBODY; PCA 2 ANTIBODY; RI ANTIBODY; TR ANTIBODY; UNCLASSIFIED DRUG; VGCC ANTIBODY; YO ANTIBODY; ZIC ANTIBODY;

ANTIBODY BLOOD LEVEL; BRAIN NERVE CELL; CEREBELLUM; CEREBROSPINAL FLUID LEVEL; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; IMMUNOTHERAPY; PARANEOPLASTIC NEUROPATHY; PATHOGENESIS; REVIEW;

ANTIGENS, NEOPLASM; AUTOANTIBODIES; BIOLOGICAL MARKERS; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; MEMBRANE PROTEINS; NEOPLASMS; NERVE TISSUE PROTEINS; PARANEOPLASTIC CEREBELLAR DEGENERATION; RNA-BINDING PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77951555160     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Croft PB, Wilkinson M: The incidence of carcinomatous neuromyopathy in patients with various types of carcinoma. Brain 88: 427-434, 1965
2. Shams'ili S, Grefkens J, de Leeuw B, van den Bent M, Hooijkaas H, et al: Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patient Brain 126: 1409-1418, 2003
3. Greenlee JE, Brashear HR: Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol 14: 609-613: 1983
4. Sakai K, Mitchell DJ, Tsukamoto T, Steinman L: Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration. Ann Neurol 28: 692-698, 1990
5. Fathallah-Shaykh H, Wolf S, Wong E, Posner JB, Furneaux HM: Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A 88: 3451-3454, 1991
6. Sakai K, Ogasawara T, Hirose G, Jaeckle KA, Greenlee JE: Analysis of autoantibody binding to 52-kd paraneoplastic cerebellar degeneration-associated antigen expressed in recombinant proteins. Ann Neurol 33: 373-380, 1993
7. Sakai K, Kitagawa Y, Saiki S, Saiki M, Hirose G: Effect of a paraneoplastic cerebellar degeneration-associated neural protein on B-myb promoter activity. Neurobiol Dis 15: 529-533, 2004
8. Sakai K, Shirakawa T, Li Y, Kitagawa Y, Hirose G: Interaction of a paraneoplastic cerebellar degeneration-associated neuronal protein with a nuclear helix-loop-helix leucine zipper protein MRG X. Mol Cell Neurosci 19: 477-484, 2002
9. Albert ML, Darnell JC, Bender A, Francisco LM, Bhardwaj N, et al: Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med 4: 1321-1324, 1998
10. Graus F, Cordon-Cardo C, Posner JB: Neuronal antinuclear antibody in sensory neuropathy from lung cancer. Neurology 35: 538-543, 1985
11. Greenlee JE, Lipton HL: Anticerebellar antibodies in serum and cerebrospinal fluid of a patient with oat cell carcinoma of the lung and paraneoplastic cerebellar degeneration. Ann Neurol 19: 82-85, 1986
12. Szabo A, Dalmau J, Manley G, Rosenfeld M, Wong E, et al: HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 67: 325-333, 1991
13. Levine TD, Gao F, King PH, Andrews LG , KeeneJD: Hel-N1: an autoimmune RNA-binding protein with specificity for 3′ uridylate-rich untranslated regions of growth factor mRNAs. Mol Cell Biol 13: 3494-3504, 1993
14. Sakai K, Gofuku M, Kitagawa Y, Ogasawara T, Hirose G et al: A hippocampal protein associated with paraneoplastic neurologic syndrome and small cell lung carcinoma. Biochem Biophys Res Commun 199: 1200-1208, 1994
15. Ma WJ, Cheng S, Campbell C, Wright A, Furneaux H: Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem 271: 8144-8151, 1996
16. Joseph B, Orlian M, Furneaux H: p21 (waf1) mRNA contains a conserved element in its 3′-untranslated region mat is bound by the Elav-like mRNA-stabilizing proteins. J Biol Chem 273: 20511-20516, 1998
17. Sakai K, Kitagawa Y, Saiki M, Saiki S, Hirose G: Binding of the ELAV-like protein in murine autoimmune T-cells to the nonameric AU-rich element in the 3′ untranslated region of CD154 mRNA. Mol Immunol 39: 879-883, 2003
18. Bataller L, Graus F, Saiz A, Vilchez JJ; Spanish Opsoclonus-Myoclonus Study Group: Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain 124: 437-443, 2001
19. Buckanovich RJ, Posner JB, Darnell RB: Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron 11: 657-672, 1993
20. Jensen KB, Dredge BK, Stefani G, Zhong R, Buckanovich RJ, et al: Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron 25: 359-371, 2000
21. Dalmau J, Graus F, Villarejo A, Posner JB, Blumenthal D, et al: Clinical analysis of anti-Ma2-associated encephalitis. Brain 127: 1831-844, 2004
22. Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, et al: CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 49: 146-154, 2001
23. Vernino S, Tuite P, Adler CH, Meschia JF, Boeve BF, et al: Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol 51: 625-630, 2002
24. Fukuda T, Motomura M, Nakao Y, Shiraishi H, Yoshimura T, et al: Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome. Ann Neurol 53: 21-28, 2003
25. 2+ currents and mimics cerebellar ataxia in vivo Proc Natl Acad Sci U S A 105: 2705-2710, 2008
26. Saiz A, Blanco Y, Sabater L, González F, Bataller L, et al: Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131: 2553-2563, 2008
27. Abele M, Weller M, Mescheriakov S, Bürk K, Dichgans J, et al: Cerebellar ataxia with glutamic acid decarboxylase autoantibodies. Neurology 52: 857-859, 1999
28. Sillevis Smitt P, Kinoshita A, De Leeuw B, Moll W, Coesmans M, et al: Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med 342: 21-27, 2000
29. Chan KH, Vernino S, Lennon VA: ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity. Ann Neurol 50: 301-311, 2001
30. Vernino S, Lennon VA: New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity. Ann Neurol 47: 297-305, 2000
31. Graus F, Dalmau J, Valldeoriola F, Ferrer I, Reñe R, et al: Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease. J Neuroimmunol 74: 55-61, 1997
32. Bataller L, Wade DF, Graus F, Stacey HD, Rosenfeld MR, et al: Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer. Neurology 62: 778-782, 2004
33. Sabater L, Bataller L, Suárez-Calvet M, Saiz A, Dalmau J, et al: ZIC antibodies in paraneoplastic cerebellar degeneration and small cell lung cancer. J Neuroimmunol 201-202: 163-165, 2008
34. Bataller L, Sabater L, Saiz A, Serra C, Claramonte B, et al: Carbonic anhydrase-related protein VIII: autoantigen in paraneoplastic cerebellar degeneration. Ann Neurol 56: 575-579, 2004
35. Coesmans M, Smitt PA, Linden DJ, Shigemoto R, Hirano T, et al: Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies. Ann Neurol 53: 325-336, 2003
36. Manto MU, Laute MA, Aguera M, Rogemond V, Pandolfo M, et al: Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol 61: 544-551, 2007
37. Sakai K, Shirakawa T, Kitagawa Y, Li Y, Hirose G: Induction of cytotoxic T lymphocytes specific for paraneoplastic cerebellar degeneration-associated antigen in vivo by DNA immunization. J Autoimmun 17: 297-302, 2001
38. Sutton IJ, Steele J, Savage CO, Winer JB, Young LS: An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies. J Neuroimmunol 150: 98-106, 2004
39. Carpenter EL, Vance BA, Klein RS, Voloschin A, Dalmau J, et al: Functional analysis of CD8+ T cell responses to the onconeural self protein cdr2 in patients with paraneoplastic cerebellar degeneration. J Neuroimmunol 193: 173-182, 2008
40. Pellkofer H, Schubart AS, Höftberger R, Schutze N, Pagany M, et al: Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat. Brain 127: 1822-1830, 2004
41. Voltz R, Dalmau J, Posner JB, Rosenfeld MR: T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology 51: 1146-1150, 1998
42. Roberts WK, Deluca IJ, Thomas A, Fak J, Williams T, et al: Patients with lung cancer and paraneoplastic Hu syndrome harbor HuD-specific type 2 CD8+ T cells. J Clin Invest 119: 2042-2051, 2009